Small bowel adenocarcinoma in a young male
A case report
Keywords:
Adenocarcinoma of the small bowel, third part of the duodenum, segmental resectionAbstract
Introduction: Adenocarcinoma of the third part of the duodenum is a rare type of tumor that has challenges in its diagnosis and management. Segmental resection with pancreatic sparing is a safe and accepted choice for the surgical intervention of this type of cancer. Case Presentation: A 33-year-old male presented with a 3-week history of symptoms of gastric outlet obstruction with anemia and weight loss. Upon investigating the patient with computed tomography and esophagogastroduodenoscopy, he was found to have an adenocarcinoma that involved the third part of the duodenum. The patient underwent segmental resection of the third and fourth part of the duodenum with pancreatic sparing. He had a smooth postoperative course. The pathological evaluation shows a 3 cm moderately differentiated adenocarcinoma with free margins. Six out of thirteen lymph nodes were having metastasis. The patient developed a soft tissue recurrence 18 months after the operation. Take-away Lessons: Adenocarcinoma of the third part of the duodenum should be kept in mind in any patient presented with symptoms of gastric outlet obstruction. It can be managed safely with segmental resection avoiding the morbidity of resection of the pancreas.References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68: 7–30. doi:
3322/caac.21442. PMID: 29313949.
Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol. 2011; 3:
–42. doi: 10.4251/wjgo.v3.i3.33. PMID: 21461167, PMCID: PMC3069308.
García-Molina FJ, Mateo-Vallejo F, Franco-Osorio J de D, Esteban-Ramos JL, Rivero-Henández I.
Surgical approach for tumours of the third and fourth part of the duodenum. Distal pancreas-sparing
duodenectomy. Int J Surg. 2015; 18: 143–8. doi: 10.1016/j.ijsu.2015.04.051. PMID: 25917202.
Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small Bowel Cancer in the
United States. Ann Surg. 2009; 249: 63–71. doi: 10.1097/SLA.0b013e31818e4641. PMID: 19106677.
Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491
cases of small bowel adenocarcinoma. Am J Surg. 2010; 199: 797–803. doi:
1016/j.amjsurg.2009.05.037. PMID: 20609724.
Lee SY, Lee JH, Hwang DW, Kim SC, Park KM, Lee YJ. Long-term outcomes in patients with duodenal
adenocarcinoma. ANZ J Surg. 2014; 84: 970–5. doi: 10.1111/ans.12112. PMID: 23656271.
Tocchi A, Mazzoni G, Puma F, Miccini M, Cassini D, Bettelli E, et al. Adenocarcinoma of the third and
fourth portions of the duodenum: results of surgical treatment. Arch Surg. 2003; 138: 80–5. doi:
1001/archsurg.138.1.80. PMID: 12511157.
Cloyd JM, Norton JA, Visser BC, Poultsides GA. Does the extent of resection impact survival for duodenal
adenocarcinoma? Analysis of 1,611 cases. Ann Surg Oncol. 2015; 22: 573–80. doi: 10.1245/s10434-014- 4020-z. PMID: 25160736.
Dorcaratto D, Heneghan HM, Fiore B, Awan F, Maguire D, Geoghegan J, et al. Segmental duodenal
resection: Indications, surgical techniques and postoperative outcomes. J Gastrointest Surg. 2015; 19: 736–
doi: 10.1007/s11605-015-2744-0. PMID: 25595309.
Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel
adenocarcinoma. PLoS One. 2018; 13: e0200204. doi: 10.1371/journal.pone.0200204. PMID: 30096150,
PMCID: PMC6086425.
Chung WC, Paik CN, Jung SH, Lee KM, Kim SW, Chang UI, et al. Prognostic factors associated with
survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med. 2011; 26: 34–40. doi:
3904/kjim.2011.26.1.34. PMID: 21437160, PMCID: PMC3056253.
Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, et al. Clinicopathological analysis and survival
outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014; 30: 254–9. doi:
1016/j.kjms.2013.12.006. PMID: 24751389.
Liang TJ, Wang BW, Liu SI, Chou NH, Tsai CC, Chen IS, et al. Number of involved lymph nodes is
important in the prediction of prognosis for primary duodenal adenocarcinoma. J Chinese Med Assoc.
; 75: 573–80. doi: 10.1016/j.jcma.2012.08.002. PMID: 23158035.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.